Optimum Communications, Inc.
—- Market cap
- —
- Debt
- —
- Cash
- −$1.01B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ATUS stock price vs LUMN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at LUMN's multiple
Needs LUMN P/S.
Implied fair value · at ATUS's multiple
Needs ATUS P/S.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Optimum Communications, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
LUMEN TECHNOLOGIES, INC. · implied price per share
Bear
-$11.13
Base
-$10.46
Bull
-$9.26
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe ATUS can stabilize revenue declines and reduce leverage from 9.4x net debt/EBITDA, then the shares look worth considering because ATUS already shows better margins and ROIC than LUMN, but the current quality and balance-sheet profile still argue for caution.
ATUS has an implied price of $15.23 under LUMN P/S framework, which sits slightly above LUMN implied range of $15.04 to $22.50 but well below the DCF range of $39.09 to $52.89. That suggests the market is likely assigning a large discount to cash flow durability and balance-sheet risk rather than just sales power.
Supporting Metrics